Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-21 · accession 0001493152-22-020281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-25 | 2022-07-21 | ABEO | CFO | A - Grant | $0.00 | +12.0K | 20.0K | +150% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-07-21 | A | A | 12,000 | $0.00 | 20,000 | D | — | — | (F1) The restricted stock will vest 25% on each of July 21, 2023, July 21, 2024, July 21, 2025 and July 21, 2026. |